Genetic response to DNA damage: Proapoptotic targets of RhoB include modules for p53 response and susceptibility to alzheimer's disease

Cancer Biology and Therapy

Volumn 4, Issue 3, 2005, Pages 282-288

  Kamasani, Uma ^a   Prendergast, George C ^a,b  

^a LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Age associated disease; Aging; Chemotherapy; Ras; Rho

Indexed keywords

DNA; DOXORUBICIN; PROTEIN; PROTEIN P53; PROTEIN RHOB; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOSKELETON; DNA DAMAGE; GENE TARGETING; GENETIC LINKAGE; GENOTOXICITY; GENOTYPE; IMMUNE RESPONSE; MOUSE; NONHUMAN; SENSITIZATION;

EID: 25144492676     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.4.3.1498     Document Type: Article

References (56)

1. Prendergast GC. Actin' up: RhoB in cancer and apoptosis. Nature Rev Cancer 2001; 1:162-8.
2. Adnane J, Muro-Cacho C, Mathews L, Sebti SM, Munoz-Antonia T. Suppression of rho b expression in invasive carcinoma from head and neck cancer patients. Clin Cancer Res 2002; 8:2225-32.
3. Mazieres J, Antonia T, Daste G, Muro-Cacho C, Berchery D, Tillement V, Pradines A, Sebti S, Favre G. Loss of RhoB expression in human lung cancer progression. Clin Cancer Res 2004; 10:2742-50.
4. Jaffe AB, Hall A. Rho gtpases in transformation and metastasis. Adv Cancer Res 2002; 84:57-80.
5. Sahai E, Marshall CJ. Rho gtpases and cancer. Nature Rev Cancer 2002; 2:133-42.
6. Liu A-X, Rane N, Liu J-P, Prendergast GC. Rhob is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells. Mol Cell Biol 2001; 21:6906-12.
7. Tovar D, Faye JC, Favre G. Cloning of the human RhoB gene promoter: Characterization of a vntr sequence that affects transcriptional activity. Genomics 2003; 81:525-30.
8. Liu A-X, Cerniglia GJ, Bernhard EJ, Prendergast GC. Rhob is required for the apoptotic response of neoplastically transformed cells to DNA damage. Proc Natl Acad Sci USA 2001; 98:6192-7.
9. Fritz G, Kaina B, Aktories K. The ras-related small gtp-binding protein RhoB is immediate-early inducible by DNA damaging treatments. J Biol Chem 1995; 270:25172-7.
10. Fritz G, Kaina B. Ras-related gtpase RhoB forces alkylation-induced apoptotic cell death. Biochem Biophys Res Comm 2000; 268:784-9.
11. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74:957-67.
12. Liu A-X, Du W, Liu J-P, Jessell TM, Prendergast GC. Rhob alteration is required for the apoptotic and antineoplastic responses to farnesyltransferase inhibitors. Mol Cell Biol 2000; 20:6105-13.
13. Du W, Lebowitz P, Prendergast GC. Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB. Mol Cell Biol 1999; 19:1831-40.
14. Tran P, Zhang XK, Salbert G, Hermann T, Lehmann JM, Pfahl M. Coup orphan receptors are negative regulators of retinoic acid response pathways. Mol Cell Biol 1992; 12:4666-76.
15. Hiroi N, Ito T, Yamamoto H, Ochiya T, Jinno S, Okayama H. Mammalian rcd1 is a novel transcriptional cofactor that mediates retinoic acid-induced cell differentiation. EMBO J 2002; 21:5235-44.
16. Wang Q, Bai Z, Li X, Hou L, Zhang B. The evidences of human orphan receptor coup-tfii inhibiting telomerase activity through decreasing htert transcription. Cancer Lett 2004; 214:81-90.
17. Xu Q, Walther N, Jiang H. Chicken ovalbumin upstream promoter transcription factor ii (coup-tfii) and hepatocyte nuclear factor 4gamma (hnf-4gamma) and hnf-4alpha regulate the bovine growth hormone receptor 1a promoter through a common DNA element. J Mol Endocrinol 2004; 32:947-61.
18. Lee CK, Klopp RG, Weindruch R, Prolla TA. Gene expression profile of aging and its retardation by caloric restriction. Science 1999; 285:1390-3.
19. Schwarze SR, DePrimo SE, Grabert LM, Fu VX, Brooks JD, Jarrard DF. Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells. J Biol Chem 2002; 277:14877-83.
20. Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O. Truncating mutations of hsnf5/ini1 in aggressive paediatric cancer. Nature 1998; 394:203-6.
21. Medjkane S, Novikov E, Versteege I, Delattre O. The tumor suppressor hsnf5/ini1 modulates cell growth and actin cytoskeleton organization. Cancer Res 2004; 64:3406-13.
22. Ahmed MM. Regulation of radiation-induced apoptosis by early growth response-1 gene in solid tumors. Curr Cancer Drug Targets 2004; 4:43-52.
23. Liu C, Rangnekar VM, Adamson E, Mercola D. Suppression of growth and transformation and induction of apoptosis by egr-1. Cancer Gene Ther 1998; 5:3-28.
24. Nair P, Muthukkumar S, Sells SF, Han SS, Sukhatme VP, Rangnekar VM. Early growth response-1-dependent apoptosis is mediated by p53. J Biol Chem 1997; 272:20131-8.
25. Gnad R, Kaina B, Fritz G. Rho gtpases are involved in the regulation of nf-kappab by genotoxic stress. Exp Cell Res 2001; 264:244-9.
26. Fritz G, Kaina B. Ras-related gtpase RhoB represses nf-kappab signaling. J Biol Chem 2001; 276:3115-22.
27. Kamasani U, Liu A-X, Prendergast GC. Genetic response to farnesyltransferase inhibitors: Proapoptotic targets of RhoB. Cancer Biol Therapy 2003; 2:273-80.
28. Dohn M, Jiang J, Chen X. Receptor tyrosine kinase epha2 is regulated by p53-family proteins and induces apoptosis. Oncogene 2001; 20:6503-15.
29. Zeng P-Y, Rane N, Du W, Chintapalli J, Prendergast GC. Role of RhoB and prk in the suppression of epithelial cell transformation by farnesyltransferase inhibitors. Oncogene 2003; 22:1124-34.
30. Lee JL, Lin CT, Chueh LL, Chang CJ. Autocrine/paracrine secreted frizzled-related protein 2 induces cellular resistance to apoptosis: A possible mechanism of mammary tumorigenesis. J Biol Chem 2004; 279:14602-9.
31. Yam JW, Zheng JY, Hsiao WL. Identification and characterization of genes whose expressions are altered in rat 6 fibroblasts transformed by mutant p53(val135). Biochem Biophys Res Commun 1999; 266:472-80.
32. Novarino G, Fabrizi C, Tonini R, Denti MA, Malchiodi-Albedi F, Lauro GM, Sacchetti B, Paradisi S, Ferroni A, Curmi PM, Breit SN, Mazzanti M. Involvement of the intracellular ion channel clic1 in microglia-mediated beta-amyloid-induced neurotoxicity. J Neurosci 2004; 24:5322-30.
33. Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC, Cervera P, Le Bouc Y. Igf-1 recpetor regulates lifespan and resistance to oxidative stress in mice. Nature 2003; 421:182-7.
34. Gampel A, Parker PJ, Mellor H. Regulation of epidermal growth factor receptor traffic by the small gtpase RhoB. Curr Biol 1999; 9:955-8.
35. Wherlock M, Gampel A, Futter C, Mellor H. Farnesyltransferase inhibitors disrupt egf receptor traffic through modulation of the RhoB gtpase. J Cell Sci 2004; 117:3221-31.
36. Dikic I. Mechanisms controlling egf receptor endocytosis and degradation. Biochem Soc Trans 2003; 31:1178-81.
37. Stahl PD, Barbieri MA. Multivesicular bodies and multivesicular endosomes: The "ins and outs" of endosomal traffic. Sci STKE 2002; 2002:PE32.
38. Ivan M, Haberberger T, Gervasi DC, Michelson KS, Gunzler V, Kondo K, Yang H, Sorokina I, Conaway RC, Conaway JW, Kaelin WG Jr. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc Natl Acad Sci USA 2002; 99:13459-64.
39. Lipscomb EA, Sarmiere PD, Freeman RS. Sm-20 is a novel mitochondrial protein that causes caspase-dependent cell death in nerve growth factor-dependent neurons. J Biol Chem 2001; 276:5085-92.
40. Gotoh T, Terada K, Mori M. Hsp70-dnaj chaperone pairs prevent nitric oxide-mediated apoptosis in raw 264.7 macrophages. Cell Death Differ 2001; 8:357-66.
41. Bushell M, Wood W, Clemens MJ, Morley SJ. Changes in integrity and association of eukaryotic protein synthesis initiation factors during apoptosis. Eur J Biochem 2000; 267:1083-91.
42. Sasaki Y, Itoh F, Suzuki H, Kobayashi T, Kakiuchi H, Hareyama M, Imai K. Identification of genes highly expressed in g2-arrested chinese hamster ovary cells by differential display analysis. J Clin Lab Anal 2000; 14:314-9.
43. Okamoto K, Li H, Jensen MR, Zhang T, Taya Y, Thorgeirsson SS, Prives C. Cyclin g recruits pp2a to dephosphorylate mdm2. Mol Cell 2002; 9:761-71.
44. Okamoto K, Prives C. A role of cyclin g in the process of apoptosis. Oncogene 1999; 18:4606-15.
45. Varmeh-Ziaie S, Okan I, Wang Y, Magnusson KP, Warthoe P, Strauss M, Wiman KG. Wig-1, a new p53-induced gene encoding a zinc finger protein. Oncogene 1997; 15:2699-704.
46. Hellborg F, Qian W, Mendez-Vidal C, Asker C, Kost-Alimova M, Wilhelm M, Imreh S, Wiman KG. Human wig-1, a p53 target gene that encodes a growth inhibitory zinc finger protein. Oncogene 2001; 20:5466-74.
47. Burton A. Nsaids and alzheimer's disease: It's only rock and rho. Lancet Neurol 2004; 3:6.
48. 47a. Pedrini S, Carter TL, Prendergast G, Petanceska S, Ehrlich ME, Gandy. Modulation of Statin-Activated Shedding of Alzheimer-APP Ectodomain by ROCK. PLoS Med 2005; 2:e18.
49. Eden S, Rohatgi R, Podtelejnikov AV, Mann M, Kirschner MW. Mechanism of regulation of wave1-induced actin nucleation by rac1 and nck. Nature 2002; 418:790-3.
50. Yamamoto A, Behl C. Human nck-associated protein 1 and its binding protein affect the metabolism of beta-amyloid precursor protein with swedish mutation. Neurosci Lett 2001; 316:50-4.
51. Yamamoto A, Suzuki T, Sakaki Y. Isolation of hnap1bp which interacts with human nap1 (nckap1) whose expression is down-regulated in alzheimer's disease. Gene 2001; 271:159-69.
52. Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, Yankner BA. Gene regulation and DNA damage in the ageing human brain. Nature 2004; 429:883-91.
53. Li L, Ren CH, Tahir SA, Ren C, Thompson TC. Caveolin-1 maintains activated akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases pp1 and pp2a. Mol Cell Biol 2003; 23:9389-404.
54. Du W, Lebowitz PF, Prendergast GC. Elevation of \alpha\2(i) collagen, a suppressor of ras transformation, is required for stable phenotypic reversion by farnesyltransferase inhibitors. Cancer Res 1999; 59:2059-63.
55. Hargrave M, Wright E, Kun J, Emery J, Cooper L, Koopman P. Expression of the sox11 gene in mouse embryos suggests roles in neuronal maturation and epithelio-mesenchymal induction. Dev Dyn 1997; 210:79-86.
56. Sevenet N, Sheridan E, Amram D, Schneider P, Handgretinger R, Delattre O. Constitutional mutations of the hsnf5/ini1 gene predispose to a variety of cancers. Am J Hum Genet 1999; 65:1342-8.